Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema
- PMID: 8689816
- DOI: 10.1016/S0009-9236(96)90161-7
Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema
Abstract
Objective: To study the association of race and other patient characteristics associated with angiotensin converting enzyme (ACE) inhibitor-associated angioedema.
Methods: This was a retrospective cohort study of participants in the Tennessee Medicaid Program ( >or= 15 years of age) to whom ACE inhibitors had been prescribed from 1986 through 1992.
Results: We identified 82 patients with confirmed angioedema during 51,752 person-years of ACE inhibitor use, giving an overall rate of angioedema of 1.6 per 1000 person-years of ACE inhibitor use. After potential confounding factors were controlled for, the adjusted relative risk (RR) of angioedema among black American users of ACE inhibitors was 4.5 (95% confidence interval [CI] 2.9 to 6.8) compared with white subjects. In addition to race, other factors associated with a significantly increased relative risk in the entire population were the first 30 days of ACE inhibitor use (RR, 4.6; 95% CI, 2.5 to 8.5) compared to > 1 year of use, use of either lisinopril (RR, 2.2; 95% CI, 1.2 to 3.9) or enalapril (RR, 2.2; 95% CI, 1.4 to 3.5) compared to captopril, and previous hospitalization for any diagnosis within 30 days (RR, 2.0; 95% CI, 1.1 to 3.6). Neither ACE inhibitor dose nor concurrent diuretic use was associated with the risk of angioedema.
Conclusions: These data suggest that black Americans have a substantially increased risk of ACE inhibitor-associated angioedema compared with white subjects and that this increased risk cannot be attributed to an effect of dose, specific ACE inhibitor, or concurrent medications.
Comment in
-
Race and angioedema.Clin Pharmacol Ther. 1997 Jun;61(6):700. doi: 10.1016/S0009-9236(97)90106-5. Clin Pharmacol Ther. 1997. PMID: 9209254 No abstract available.
Similar articles
-
Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema.Pharmacogenet Genomics. 2010 Sep;20(9):532-6. doi: 10.1097/FPC.0b013e32833d3acb. Pharmacogenet Genomics. 2010. PMID: 20625347 Free PMC article.
-
Recurrent angiotensin-converting enzyme inhibitor--associated angioedema.JAMA. 1997 Jul 16;278(3):232-3. doi: 10.1001/jama.278.3.232. JAMA. 1997. PMID: 9218671
-
Angiotensin converting enzyme inhibitor-induced gastrointestinal angioedema: a case series and literature review.J Clin Gastroenterol. 2013 Nov-Dec;47(10):844-9. doi: 10.1097/MCG.0b013e318299c69d. J Clin Gastroenterol. 2013. PMID: 23751839 Review.
-
Long-acting ACE inhibitor-induced angioedema.Allergy Proc. 1992 Mar-Apr;13(2):85-7. doi: 10.2500/108854192778878845. Allergy Proc. 1992. PMID: 1316863
-
Angiotensin-converting enzyme inhibitor-associated angioedema.Immunol Allergy Clin North Am. 2006 Nov;26(4):725-37. doi: 10.1016/j.iac.2006.08.001. Immunol Allergy Clin North Am. 2006. PMID: 17085287 Review.
Cited by
-
Cerebral angioedema associated with enalapril.Br J Clin Pharmacol. 2009 Aug;68(2):271-3. doi: 10.1111/j.1365-2125.2009.03452.x. Br J Clin Pharmacol. 2009. PMID: 19694749 Free PMC article. No abstract available.
-
Caution in diagnosing angioedema as anaphylaxis.BMJ Case Rep. 2019 Sep 4;12(9):e230329. doi: 10.1136/bcr-2019-230329. BMJ Case Rep. 2019. PMID: 31488445 Free PMC article.
-
Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema.Pharmacogenet Genomics. 2010 Sep;20(9):532-6. doi: 10.1097/FPC.0b013e32833d3acb. Pharmacogenet Genomics. 2010. PMID: 20625347 Free PMC article.
-
Angioedema: clinical and etiological aspects.Clin Dev Immunol. 2007;2007:26438. doi: 10.1155/2007/26438. Clin Dev Immunol. 2007. PMID: 18317527 Free PMC article.
-
Five-Membered Nitrogen Heterocycles Angiotensin-Converting Enzyme (ACE) Inhibitors Induced Angioedema: An Underdiagnosed Condition.Pharmaceuticals (Basel). 2024 Mar 10;17(3):360. doi: 10.3390/ph17030360. Pharmaceuticals (Basel). 2024. PMID: 38543146 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous